Mark Wildgust
@mawildgust.bsky.social
VP of Oncology Global Medical Affairs at Johnson & Johnson focused on bringing new treatment options for patients with cancer. Posts shared are my own. 🇬🇧🇺🇸🏳️🌈
Pinned
Mark Wildgust
@mawildgust.bsky.social
· Nov 22
Happy to join the Bluesky community.
Reposted by Mark Wildgust
A Comment article in Nature Medicine argues that clinical research should recruit participants from LGBTQIA+ populations, which requires specific actions and policies to create affirming and welcoming environments. https://go.nature.com/3WILuQi 🧪
February 3, 2025 at 1:04 PM
A Comment article in Nature Medicine argues that clinical research should recruit participants from LGBTQIA+ populations, which requires specific actions and policies to create affirming and welcoming environments. https://go.nature.com/3WILuQi 🧪
Our mission @J&J is to understand how our medicines work in all pts. I’m honored to have contributed to this ground breaking paper in @naturemedicine.bsky.social identifying a roadmap for inclusion of #LGBTQIA+ individuals. @fenwayhealth.bsky.social #MyCompany
www.nature.com/articles/s41...
www.nature.com/articles/s41...
A roadmap for engagement and inclusion of LGBTQIA+ people in clinical research - Nature Medicine
Clinical research should recruit participants from LGBTQIA+ populations, and this requires specific actions and policies to create affirming and welcoming environments.
www.nature.com
February 9, 2025 at 3:54 PM
Our mission @J&J is to understand how our medicines work in all pts. I’m honored to have contributed to this ground breaking paper in @naturemedicine.bsky.social identifying a roadmap for inclusion of #LGBTQIA+ individuals. @fenwayhealth.bsky.social #MyCompany
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Excited to share our #SKIPPirr study was just published. Great job everyone involved in this study. #EGFR #NSCLC #PatientFocus #MyCompany
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Brief Report: Preventing Infusion-related Reactions With Intravenous Amivantamab: Results From SKIPPirr, a Phase 2 Study
Amivantamab, an EGFR–MET bispecific antibody, is approved for multiple indications in EGFR-mutated advanced non-small cell lung cancer (NSCLC) as mono…
www.sciencedirect.com
January 26, 2025 at 2:23 PM
Excited to share our #SKIPPirr study was just published. Great job everyone involved in this study. #EGFR #NSCLC #PatientFocus #MyCompany
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Great to speak at the @statnews.bsky.social panel Stat@ash on our goals in #hematology driving towards transforming outcomes in cancer. #MyCompany
December 8, 2024 at 4:20 AM
Great to speak at the @statnews.bsky.social panel Stat@ash on our goals in #hematology driving towards transforming outcomes in cancer. #MyCompany
Great to see the discussion by @statnews.bsky.social on #Sicklecell here #ASH24 at their STAT@ASH event. Great moderating by @adamfeuerstein.bsky.social
December 8, 2024 at 3:07 AM
Great to see the discussion by @statnews.bsky.social on #Sicklecell here #ASH24 at their STAT@ASH event. Great moderating by @adamfeuerstein.bsky.social
Excited to be speaking on the @statnews.bsky.social panel this evening at #ASH24. Speaking on the innovations in hematology that Johnson & Johnson Innovative Medicine are leading and pioneering. #MyCompany
December 8, 2024 at 2:54 AM
Excited to be speaking on the @statnews.bsky.social panel this evening at #ASH24. Speaking on the innovations in hematology that Johnson & Johnson Innovative Medicine are leading and pioneering. #MyCompany
Great to see the Bleximenib data being presented here at #ASH24! More progress is needed in AML! #MyCompany
December 7, 2024 at 11:05 PM
Great to see the Bleximenib data being presented here at #ASH24! More progress is needed in AML! #MyCompany
Love being at #ASH24. Finding time to grab something to east isn’t easy! But when you find a snack in a meeting room …. #Hungry
a cookie monster is sitting on a kitchen counter next to a measuring cup that says rachael
ALT: a cookie monster is sitting on a kitchen counter next to a measuring cup that says rachael
media.tenor.com
December 6, 2024 at 7:37 PM
Heading to #ASH24. Didn’t think there was such a thing as a red eye from the East coast to the West but will land at 2:30am EST in San Diego. 🥱😴.
December 5, 2024 at 2:16 AM
Heading to #ASH24. Didn’t think there was such a thing as a red eye from the East coast to the West but will land at 2:30am EST in San Diego. 🥱😴.
As I leave Hong Kong to head home I’m reflecting on a great visit. Strengthening friendships, building new friendships, leading with science and as my friend @tonymokum.bsky.social says over good food!
November 26, 2024 at 1:39 AM
As I leave Hong Kong to head home I’m reflecting on a great visit. Strengthening friendships, building new friendships, leading with science and as my friend @tonymokum.bsky.social says over good food!
Come and join the J&J sponsored satellite symposium here at #IOHK24. Great speaker line up. #MyCompany
November 24, 2024 at 5:33 AM
Come and join the J&J sponsored satellite symposium here at #IOHK24. Great speaker line up. #MyCompany
Terrific key note presentation by Tony Mok here at #IOHK24 on immunotherapy in #LungCancer.
November 24, 2024 at 2:05 AM
Terrific key note presentation by Tony Mok here at #IOHK24 on immunotherapy in #LungCancer.
Great to catch up with @antoniopassaro.bsky.social while at the #IOHK24 meeting.
November 23, 2024 at 2:43 PM
Great to catch up with @antoniopassaro.bsky.social while at the #IOHK24 meeting.
Spectacular talk by Prof Maximilian Diehn on ctDNA and MRD in #LungCancer here at #IOHK24!
November 23, 2024 at 4:16 AM
Spectacular talk by Prof Maximilian Diehn on ctDNA and MRD in #LungCancer here at #IOHK24!
Looking forward to @solangepeters.bsky.social presentation here at #IOHK24!
November 23, 2024 at 2:48 AM
Looking forward to @solangepeters.bsky.social presentation here at #IOHK24!
November 23, 2024 at 1:31 AM
In Hong Kong for the Immuno-Oncology meeting. Also got to meet a famous local HK resident/TV star!
November 22, 2024 at 10:50 AM
In Hong Kong for the Immuno-Oncology meeting. Also got to meet a famous local HK resident/TV star!
Heading to #ASH24? Love to connect and reconnect with anyone going. Johnson & Johnson Innovative Medicine team will be there in full force, presenting new data across our hematology portfolio. #Mycompany
November 22, 2024 at 10:36 AM
Heading to #ASH24? Love to connect and reconnect with anyone going. Johnson & Johnson Innovative Medicine team will be there in full force, presenting new data across our hematology portfolio. #Mycompany
Happy to join the Bluesky community.
November 22, 2024 at 10:27 AM
Happy to join the Bluesky community.